BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21481096)

  • 1. Impact of palliative urinary diversion by percutaneous nephrostomy drainage and ureteral stenting among patients with advanced cervical cancer and obstructive uropathy: a prospective cohort.
    Lapitan MC; Buckley BS
    J Obstet Gynaecol Res; 2011 Aug; 37(8):1061-70. PubMed ID: 21481096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases.
    Ishioka J; Kageyama Y; Inoue M; Higashi Y; Kihara K
    J Urol; 2008 Aug; 180(2):618-21; discussion 621. PubMed ID: 18554655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pelvic radiotherapy in patients with hydronephrosis in stage IIIB cancer of the cervix: renal effects and the optimal timing for urinary diversion?
    Horan G; McArdle O; Martin J; Collins CD; Faul C
    Gynecol Oncol; 2006 Jun; 101(3):441-4. PubMed ID: 16337996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncological and functional outcome of radical cystectomy in patients with bladder cancer and obstructive uropathy.
    Gupta NP; Kolla SB; Seth A; Hemal AK; Dogra PN; Kumar R
    J Urol; 2007 Oct; 178(4 Pt 1):1206-11; discussion 1211. PubMed ID: 17698145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Affecting Survival Outcome After Percutaneous Nephrostomy as Palliative Urinary Diversion in Obstructive Uropathy due to Advance Cervical Cancer Patients.
    Noegroho BS; Kurniawan AP; Wijayanti Z; Mustafa A
    Asian Pac J Cancer Prev; 2021 Apr; 22(4):1211-1216. PubMed ID: 33906314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relief of upper urinary tract obstruction in patients with cancer of the prostate].
    Kraemer PC; Borre M
    Ugeskr Laeger; 2009 Mar; 171(11):873-6. PubMed ID: 19278608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous nephrostomy and ureteral stenting in gynecologic malignancies.
    Barton DP; Morse SS; Fiorica JV; Hoffman MS; Roberts WS; Cavanagh D
    Obstet Gynecol; 1992 Nov; 80(5):805-11. PubMed ID: 1407920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of percutaneous nephrostomy in malignant ureteric obstruction.
    Wilson JR; Urwin GH; Stower MJ
    Ann R Coll Surg Engl; 2005 Jan; 87(1):21-4. PubMed ID: 15720902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the success of retrograde stenting for managing ureteral obstruction.
    Yossepowitch O; Lifshitz DA; Dekel Y; Gross M; Keidar DM; Neuman M; Livne PM; Baniel J
    J Urol; 2001 Nov; 166(5):1746-9. PubMed ID: 11586215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous nephrostomy versus ureteral stents for diversion of hydronephrosis caused by stones: a prospective, randomized clinical trial.
    Mokhmalji H; Braun PM; Martinez Portillo FJ; Siegsmund M; Alken P; Köhrmann KU
    J Urol; 2001 Apr; 165(4):1088-92. PubMed ID: 11257644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of locally advanced cervical cancer presenting with obstructive uropathy: An institutional audit.
    Salunkhe R; Chopra S; Kulkarni S; Shetty N; Engineer R; Mahantshetty U; Ghosh J; Gupta S; Shrivastava SK
    Indian J Cancer; 2020; 57(4):416-422. PubMed ID: 33078748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of hydronephrosis on outcome of stage IIIB cervical cancer patients with disease limited to the pelvis, treated with radiation and concurrent chemotherapy: a Gynecologic Oncology Group study.
    Rose PG; Ali S; Whitney CW; Lanciano R; Stehman FB
    Gynecol Oncol; 2010 May; 117(2):270-5. PubMed ID: 20181381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of ureteral obstruction due to advanced malignancy: optimizing therapeutic and palliative outcomes.
    Kouba E; Wallen EM; Pruthi RS
    J Urol; 2008 Aug; 180(2):444-50. PubMed ID: 18550089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous nephrostomy vs ureteral stent for hydronephrosis secondary to ureteric calculi: impact on spontaneous stone passage and health-related quality of life-a prospective study.
    de Sousa Morais N; Pereira JP; Mota P; Carvalho-Dias E; Torres JN; Lima E
    Urolithiasis; 2019 Dec; 47(6):567-573. PubMed ID: 30219938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life and survival in advanced cervical cancer: a Gynecologic Oncology Group study.
    Chase DM; Huang HQ; Wenzel L; Cella D; McQuellon R; Long HJ; Moore DH; Monk BJ
    Gynecol Oncol; 2012 May; 125(2):315-9. PubMed ID: 22307062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obstructive uropathy in gynecologic malignancy. Detrimental effect of intraureteral stent placement and value of percutaneous nephrostomy.
    Hyppolite JC; Daniels ID; Friedman EA
    ASAIO J; 1995; 41(3):M318-23. PubMed ID: 8573816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of obstructive uropathy in advanced prostate cancer.
    Oefelein MG
    Urology; 2004 Jun; 63(6):1117-21. PubMed ID: 15183963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Life after total laryngectomy: a measure of long-term survival, function, and quality of life.
    Woodard TD; Oplatek A; Petruzzelli GJ
    Arch Otolaryngol Head Neck Surg; 2007 Jun; 133(6):526-32. PubMed ID: 17576901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival Outcome of Urinary Diversion in Advanced Cervical Cancer Patients with Hydronephrosis.
    Dhani FK; Daryanto B; Seputra KP
    Asian Pac J Cancer Prev; 2023 Aug; 24(8):2641-2646. PubMed ID: 37642049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.